Enrique Faugier-Fuentes

Enrique Faugier-Fuentes

Auto-generated profile, based on publicly available information

Enrique Faugier-Fuentes

Pediatric Rheumatology Department, Hospital Infantil de México Federico Gómez, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
LVLucio Ventura-Ríos
Lucio Ventura-Ríos
EFEnrique Faugier
Enrique Faugier
LBLaura Barzola
Laura Barzola
LCL. B. De la Cruz-Becerra
L. B. De la Cruz-Becerra
GSGuadalupe Sánchez-Bringas
Guadalupe Sánchez-Bringas
CHCristina Hernández-Díaz
Cristina Hernández-Díaz
Musculoskeletal Ultrasonography (MSUS) is an important tool for the clinical assessment in Juvenile Idiopathic Arthritis (JIA). The objective of this study was to evaluate the reliability of MSUS to detect elementary lesions: synovitis, tenosynovitis, cartilage damage and bone erosions in the wrist and metacarpal (MCP) joints of patients with JIA. Thirty children in various subgroups of JIA according to ILAR criteria, were included in this cross-sectional study. Clinical data including painful, swollen and limited joints were recorded. Five rheumatologist ultrasonographers, blinded to the clinical evaluation, evaluated the presence of elementary lesions in the wrist and MCP 2 and 3 joints bilaterally. The synovitis was graded in B-Mode and Power Doppler (PD). In addition to descriptive statistics intra- and inter-observer reliability was calculated using Cohen’s kappa according to Landis and Koch. US detected more synovitis than the clinical examination (62% vs 28%, 30% vs 23% and 22% vs 17% in the wrist, second and third MCP joints respectively). The intra-observer concordance for synovitis in all joints was excellent in B-Mode (k 0.84 .63–1.0 p = 0.001), except for MCP 2, where it was good (0.61, IC 95% .34–89, p = 0.001). For both modalities (PD, B-Mode) tenosynovitis, cartilage damage and bone erosions it was also excellent. Regarding synovitis grading the concordance was excellent for all grades (0.83–1.0, IC 95% 0.51.1.0, p = 0.001), except for grade 1 where it was good (0.61, IC 95% 0.43–.83, p = 0.001). Reliability inter-observer for grayscale synovitis (0.67–0.95, IC 95% 0.67–1.0, p = 0.001), tenosynovitis grayscale (0.89, IC 95% 0.78–0.99, p.001), damage cartilage (0.89, IC 95% 0.78–0.99, p = 0.001), PD (0.66, IC 95% 0.39–1.0, p = 0.001). The concordance for grading synovitis was excellent, but for grayscale grade 1 and 2 (.66, IC 95% .53–.74, p = 0.007) and PD grade 1 and 2 (0.63, IC 95% .58–.91, p = 004) was good. The intra- and inter-observer reliability of MSUS for inflammatory and structural lesions is good to excellent for the wrist and MCP in patients with JIA.

12 January 2014 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
YFYolanda Fuentes
Yolanda Fuentes
AHAna María Hernández
Ana María Hernández
PGPilar García-Roca
Pilar García-Roca
SVSaúl Valverde
Saúl Valverde
LVLuis Fernando Velásquez-Jones
Luis Fernando Velásquez-Jones
MMMara Medeiros
Mara Medeiros

25 November 2014 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
MGMembers of our collaborative group
Members of our collaborative group
LMLakshmi Nandini Moorthy
Lakshmi Nandini Moorthy
ERElizabeth Roy
Elizabeth Roy
VKVamsi Kurra
Vamsi Kurra
MPMargaret Ge Peterson
Margaret Ge Peterson
SBSusanne Maria Benseler
Susanne Maria Benseler
Rheumatic diseases in children are associated with significant morbidity andpoor health-related quality of life (HRQOL). There is no health-relatedquality of life (HRQOL) scale available specifically for children with lesscommon rheumatic diseases. These diseases share several features withsystemic lupus erythematosus (SLE) such as their chronic episodic nature,multi-systemic involvement, and the need for immunosuppressive medications.HRQOL scale developed for pediatric SLE will likely be applicable tochildren with systemic inflammatory diseases. We adapted Simple Measure of Impact of Lupus Erythematosus in Youngsters(SMILEY©) to Simple Measure of Impact of Illness in Youngsters(SMILY©-Illness) and had it reviewed by pediatric rheumatologists forits appropriateness and cultural suitability. We tested SMILY©-Illnessin patients with inflammatory rheumatic diseases and then translated it into28 languages. Nineteen children (79% female, n=15) and 17 parents participated. The meanage was 12±4 years, with median disease duration of 21 months (1-172months). We translated SMILY©-Illness into the following 28 languages:Danish, Dutch, French (France), English (UK), German (Germany), German(Austria), German (Switzerland), Hebrew, Italian, Portuguese (Brazil),Slovene, Spanish (USA and Puerto Rico), Spanish (Spain), Spanish(Argentina), Spanish (Mexico), Spanish (Venezuela), Turkish, Afrikaans,Arabic (Saudi Arabia), Arabic (Egypt), Czech, Greek, Hindi, Hungarian,Japanese, Romanian, Serbian and Xhosa. SMILY©-Illness is a brief, easy to administer and score HRQOL scale forchildren with systemic rheumatic diseases. It is suitable for use acrossdifferent age groups and literacy levels. SMILY©-Illness with itsavailable translations may be used as useful adjuncts to clinical practiceand research.

12 August 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
HMHéctor Menchaca-Aguayo
Héctor Menchaca-Aguayo
DADeshire Alpizar-Rodriguez
Deshire Alpizar-Rodriguez
PRPamela Ramos-Tiñini
Pamela Ramos-Tiñini
EFEnrique Faugier-Fuentes
Enrique Faugier-Fuentes
Objectives: To describe characteristics of patients with the pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS)/multisystem inflammatory syndrome in children (MIS-C) and to identify factors associated with admission to the pediatric intensive care unit (PICU) in the Mexican children without coronavirus disease 2019 (COVID-19) vaccination.Methods: This was a cross-sectional study performed at Hospital Infantil de Mexico Federico Gomez, a referral children's hospital in Mexico. The study included all cases that met the criteria for PIMS-TS/MIS-C, unvaccinated, between March 2020 and January 2022. The primary outcome was the admission to PICU. Associations of PICU admission with demographic and clinical variables were estimated using logistic regression analyses.Results: We identified a total of 90 cases, with a median age of 7.5 years old, 47 (52.2%) girls. A previously healthy status was recorded in 76 (85%) children. All patients had positive PCR, serology test, or COVID-19 exposure. PICU admission was reported in 41 (45.6%) children. No deaths were reported. Patients received as treatment only corticosteroids in 53.3% of the cases. In univariable analyses, baseline factors associated with PICU admission were older age, hypotension or shock, positive PCR test, hypoalbuminemia, elevated procalcitonin, ferritin, and lymphopenia. Age, shock at admission, and hypoalbuminemia remained independently associated in the multivariable analysis adjusted by gender and previously healthy status.Conclusion: We found a high proportion of previously healthy children in patients with PIMS-TS/MIS-C in our center. Critical care attention was received by nearly half of the children. The main treatment used was steroids. Age, shock at admission, and hypoalbuminemia were factors associated with PICU admission.

7 November 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
PRPamela Ramos-Tiñini
Pamela Ramos-Tiñini
HMHéctor Menchaca-Aguayo
Héctor Menchaca-Aguayo
DADeshire Alpizar-Rodriguez
Deshire Alpizar-Rodriguez
EMEsther Mercedes-Pérez
Esther Mercedes-Pérez
EFEnrique Faugier-Fuentes
Enrique Faugier-Fuentes
Objective: Apply the PRINTO classification proposal for diagnosing Juvenile Idiopathic Arthritis (JIA) to Mexican patients, analyzing demographic, clinical, and laboratory characteristics.Material and methods: Cross-sectional study analyzing patients diagnosed with JIA using International League of Associations for Rheumatology (ILAR 2001) criteria over two years at a national rheumatic disease center. Reclassification was done using the Pediatric Rheumatology International Trials Organization (PRINTO) proposal. Comparisons were made between antinuclear antibodies (ANAs) positive vs. negative and rheumatoid factor (RF) positive vs. negative patients.Results: Seventy-six patients were analyzed, mostly female. Median age was lower in systemic JIA (sJIA) and early onset JIA with positive ANAs (eoANA JIA). ANAs was present in 78.6% of patients. Reclassification according to PRINTO disorders showed RF positive polyarticular JIA, sJIA, and enthesitis-related JIA (ER JIA) reclassified to RF JIA, sJIA, and enthesitis/spondylitis-related JIA (ESR JIA) by 100%, 94.7%, and 80%, respectively. The ILAR category with the most variation was RF negative polyarticular JIA. Early disease onset was associated with a lower probability of positive RF after adjusting for sex, age, and ANAs. No association was found between ANAs positive vs. negative in adjusted multivariate analysis.Conclusions: We found compatibility of sJIA, RF positive polyarticular JIA, and RE JIA categories with sJIA, RF JIA, and ESR JIA disorders, respectively. Differences were noted in variables such as sex and the number of affected joints. There was high ANAs positivity; however, few patients were classified into eoANA JIA disorder, with only one presenting uveitis. Most patients were classified as other JIA.

24 October 2025 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
HMHéctor Menchaca-Aguayo
Héctor Menchaca-Aguayo
DADeshire Alpízar-Rodríguez
Deshire Alpízar-Rodríguez
CLCandy León-Rodríguez
Candy León-Rodríguez
RGRita Gutiérrez-Hernández
Rita Gutiérrez-Hernández
EFEnrique Faugier-Fuentes
Enrique Faugier-Fuentes
Objective: To describe the use and mortality-associated factors of therapeutic plasma exchange (TPE) in children with autoimmune diseases at a tertiary pediatric hospital in Mexico. Methods: Retrospective cross-sectional study including patients under 18 years old with autoimmune diseases who underwent TPE between 2022 and 2025 at the Hospital Infantil de México Federico Gómez. Demographic, clinical, therapeutic, and laboratory data were analyzed. Clinical response and mortality-associated factors were assessed. Results: Forty-one patients were included (68% female; median age: 12 years). The most frequent indications for TPE were systemic lupus erythematosus (SLE) (56.1%) and autoimmune encephalitis (14.6%). Other diagnoses included macrophage activation syndrome (MAS) ( n = 3), overlap syndromes ( n = 3), juvenile dermatomyositis ( n = 2), and single cases of ANCA-associated vasculitis, Takayasu arteritis, antiphospholipid syndrome (APS), and Kawasaki disease. Complete or partial remission was achieved in 85.4% of cases, with variable responses depending on the underlying condition. TPE was well tolerated, with few adverse events. Overall mortality was 14.6% ( n = 6), all due to sepsis ( p < 0.001). Deceased patients had higher pre-TPE levels of CRP, procalcitonin, and ferritin, though not statistically significant. Longer disease duration was significantly associated with increased mortality in both univariable (OR 1.05, 95% CI 1.01–1.10; p = 0.04) and multivariable analysis adjusted for age, sex, and SLE diagnosis (OR 1.06; 95% CI 1.01–1.14; p = 0.04). Among SLE patients without sepsis, MEX-SLEDAI scores improved significantly. Conclusion: TPE was safe and beneficial in children with severe autoimmune diseases. Mortality was related to disease duration rather than the procedure itself.